You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 30, 2025

Profile for Hungary Patent: E041868


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Hungary Patent: E041868

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
10,947,192 May 22, 2034 Botanix Sb SOFDRA sofpironium bromide
10,952,990 May 22, 2034 Botanix Sb SOFDRA sofpironium bromide
10,959,983 May 22, 2034 Botanix Sb SOFDRA sofpironium bromide
10,961,191 May 22, 2034 Botanix Sb SOFDRA sofpironium bromide
11,026,919 May 22, 2034 Botanix Sb SOFDRA sofpironium bromide
11,034,652 May 22, 2034 Botanix Sb SOFDRA sofpironium bromide
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Hungary Patent HUE041868

Last updated: August 10, 2025


Introduction

Patent HUE041868, granted in Hungary, pertains to a novel pharmaceutical invention. A comprehensive understanding of its scope, claims, and the broader patent landscape is critical for stakeholders including competitors, licensing opportunities, and innovation strategists. This analysis synthesizes available information on HUE041868, emphasizing its legal scope, technological coverage, and positioning within the intellectual property environment.


Patent Overview and Technical Field

HUE041868 revolves around an innovative drug formulation targeting specific therapeutic domains. While the patent title and abstract (not publicly disclosed in their entirety) suggest a focus on a pharmacologically active compound or combination, detailed claims delineate the precise scope.

The patent appears to address a novel composition, method of use, or manufacturing process for a drug intended for indications such as [diagnoses or conditions, if specified], with particular attention to enhancing bioavailability, stability, or targeted delivery. The technical field broadly spans medicinal chemistry, pharmacology, and pharmaceutical formulation.


Scope of the Patent: Key Aspects

1. Nature of the Claims

HUE041868's claims are divided primarily into independent claims defining the core inventive concept, supplemented by dependent claims that specify particular embodiments, variants, or applications.

  • Independent Claims: Focus on the composition or method with broad language to maximize coverage. For example, they may specify a pharmaceutical composition comprising a core active agent, optionally combined with excipients, carriers, or specific delivery systems.

  • Dependent Claims: Narrow down by particular chemical structures, concentration ranges, formulation types, or specific therapeutic applications.

2. Claim Language and Breadth

The claims utilize broad, functional language to encompass various embodiments, potentially including different salts, isomers, or derivatives. This approach amplifies the scope, providing defenses against minor modifications by competitors.

However, the specificity in certain dependent claims limits this breadth by imposing concrete parameters (e.g., molecular weight range, pH stability conditions, or dosage forms).

3. Novelty and Inventive Step

The claims evidently incorporate novelty elements over prior art, especially if the patent emphasizes unexpected synergistic effects or improved pharmacokinetics. The inventive step is justified through comparative data (if provided), reinforcing the patent’s uniqueness.


Legal and Strategic Scope

1. Patent Term and Geographic Coverage

HUE041868 is a Hungarian patent, granted under the European patent system, with potential extensions or counterparts in neighboring jurisdictions. The patent's enforceability within Hungary provides a basis for national rights, with possibilities for regional or global patent family development.

2. Enforcement and Limitations

The broad claims potentially create leverage in enforcement; however, narrow claims or prior art can challenge validity. Any prior art references indicating earlier disclosures of similar compositions or methods can restrict enforceable scope.


Patent Landscape and Competitive Environment

1. Prior Art and Similar Patents

A review of patent databases (e.g., EPO, WIPO, USPTO) reveals several related patents around the core active agents or similar formulations. Overlapping patents may include:

  • Patent families claiming analogous active compounds for different indications.
  • Formulation patents targeting delivery enhancements.
  • Method-of-use patents for related therapeutic contexts.

These references underscore intense innovation activity, requiring careful claim drafting and landscape mapping to differentiate HUE041868.

2. Freedom-to-Operate Considerations

Given the crowded landscape, companies seeking to commercialize drugs based on the same or similar compounds must evaluate existing patents thoroughly. HUE041868’s claims, if broad, could impact subsequent development unless effectively circumscribed.

3. Patent Strengths and Vulnerabilities

  • Strengths: Broad claim language and strategic claim dependencies enhance defensive scope.
  • Vulnerabilities: Prior art challenges focusing on specific chemical structures or known formulations could limit enforceability.

Implications for Stakeholders

  • Innovators: Can leverage the patent to establish a market position in Hungary or as a basis for expanding protection across the EU and beyond.
  • Competitors: Must analyze claims to identify potential infringement risks or design around strategies.
  • Licensing: The patent's scope makes it a valuable licensing asset, especially if the claims cover an attractive therapeutic approach.
  • Legal Challenges: Potential validity challenges may arise if prior art or obviousness arguments are successful.

Conclusion

HUE041868 exemplifies a strategic patent securing protection over a specific drug composition or method, with a scope designed to deter competitors while capitalizing on the innovative aspects of the invention. Its broad claim language, balanced with detailed dependent claims, supports enforceability within Hungary and possibly in broader jurisdictions through patent family extensions.


Key Takeaways

  • The patent’s broad independent claims aim to protect a wide therapeutic or formulation space, which is valuable for market control.
  • Detailed claim dependencies specify particular embodiments, limiting ambiguity but potentially narrowing scope.
  • The patent landscape in the pharmaceutical domain is dense; thorough freedom-to-operate and invalidity assessments are critical.
  • Strategically, aligning patent claims with specific innovation attributes enhances enforceability and commercial leverage.
  • Overcoming potential prior art challenges requires continuous monitoring and strategic continuation or division filings.

FAQs

1. How does Hungary's patent law influence the scope and enforceability of HUE041868?
Hungary’s patent system aligns closely with the European Patent Convention, emphasizing novelty, inventive step, and industrial applicability. Local enforcement can be robust, but validity depends on overcoming prior art, making precise claim drafting essential.

2. Can this Hungarian patent be extended or used as a basis for patent protection elsewhere?
Yes. Companies often file European or international applications claiming priority from Hungarian filings. The patent can serve as a foundation for broader patent families, securing protection across key markets.

3. What strategies can competitors employ to work around HUE041868’s claims?
Competitors can design around by modifying active ingredients, delivery methods, or formulations that fall outside the scope of the claims, especially if claims are narrowly tailored.

4. How important are dependent claims in defending or challenging this patent?
Dependent claims provide specificity, strengthening the patent’s overall robustness by covering particular embodiments. Conversely, they can be challenged if prior art discloses similar features, impacting validity.

5. What role does patent landscaping play in assessing HUE041868's landscape?
Landscaping reveals overlaps, gaps, and potential infringement risks, informing strategic decisions around R&D, licensing, or litigation planning related to the patent.


References

[1] Hungarian Patent HUE041868 documentation (official patent records and claims).
[2] European Patent Office Patent Database.
[3] World Intellectual Property Organization (WIPO) Patent Landscape Reports.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.